In-vitro diagnostic platform that performs antibiotic susceptibility testing in one hour directly from the sample.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Seed Dutch ShanX Medtech closed an oversubscribed €15 million seed led by Borski Fund to clinically validate and launch its rapid diagnostics against antibiotic resistance. | $17.4M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.